{"id":16023,"date":"2019-11-15T15:43:11","date_gmt":"2019-11-15T14:43:11","guid":{"rendered":"https:\/\/www.hollandbio.nl\/?p=16023"},"modified":"2019-11-19T15:49:33","modified_gmt":"2019-11-19T14:49:33","slug":"biosana-and-astar-to-advance-continuous-biomanufacturing","status":"publish","type":"post","link":"https:\/\/www.hollandbio.nl\/en\/nieuws\/biosana-and-astar-to-advance-continuous-biomanufacturing\/","title":{"rendered":"Biosana and A*STAR to advance continuous biomanufacturing"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">BiosanaPharma and A*STAR\u2019s Bioprocessing Technology Institute (BTI) have signed a research collaboration to bring continuous biomanufacturing to the next level. Biosana\u2019s proprietary 3C process will be used as the model for:<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>Downscaling of continuous processing to facilitate fast-track process development for innovator and biosimilar monoclonal antibodies (mAbs)<\/li><li>In-line and at-line process analytical monitoring of continuous process to bring parametric release closer to reality<\/li><li>Modelling of continuous processing for easy scale up and<\/li><li>High throughput process development of Biosana\u2019s mAb antibody candidates to validate the achievements<\/li><\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">The parties will establish a Joint Laboratory for Continuous\nBiomanufacturing located at the Centros building in Biopolis, Singapore, where\nstaff from both parties will collaborate to mature and optimize the continuous process.\nBiosana will incorporate a local entity to support the collaboration.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">To address the current challenges of diverse product\npipelines and competition from biosimilars, companies are looking for highly\nflexible and cost effective manufacturing processes, traits that continuous\nbiomanufacturing can offer. Continuous biomanufacturing can directly lower the\ncosts of mAb therapeutics to benefit patients and reimbursement bodies.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Ard Tijsterman, CEO of BiosanaPharma commented \u201cWe are very\nhappy to start this Joint Laboratory in collaboration with BTI. In the past\nyears we\u2019ve been working with BTI, we are impressed by their dedication,\nexpertise and enthusiasm for our joint process development activities. We look\nforward to mature our 3C technology in order to increase accessibility and\naffordability of mAb medicines\u201d.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201cWe are pleased to be a partner in setting up this Joint Laboratory, leveraging BTI\u2019s expertise in bioprocessing science and engineering. This affirms our commitment to work with international enterprises to develop innovative biomanufacturing solutions, meet the demands of the global biopharmaceutical industry, and add to the vibrancy of Singapore\u2019s R&amp;D ecosystem\u201d, said Professor Lam Kong-Peng, Executive Director, Bioprocessing Technology Institute, A*STAR.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Source: BiosanaPharma<\/p>\n","protected":false},"excerpt":{"rendered":"<p>BiosanaPharma and A*STAR\u2019s Bioprocessing Technology Institute (BTI) have signed a research collaboration to bring continuous biomanufacturing to the next level. Biosana\u2019s proprietary 3C process will be used as the model for: Downscaling of continuous processing to facilitate fast-track process development for innovator and biosimilar monoclonal antibodies (mAbs) In-line and at-line process analytical monitoring of continuous [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[43],"tags":[],"class_list":["post-16023","post","type-post","status-publish","format-standard","hentry","category-innovatieklimaat"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Biosana and A*STAR to advance continuous biomanufacturing - hollandbio<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.hollandbio.nl\/en\/nieuws\/biosana-and-astar-to-advance-continuous-biomanufacturing\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Biosana and A*STAR to advance continuous biomanufacturing - hollandbio\" \/>\n<meta property=\"og:description\" content=\"BiosanaPharma and A*STAR\u2019s Bioprocessing Technology Institute (BTI) have signed a research collaboration to bring continuous biomanufacturing to the next level. Biosana\u2019s proprietary 3C process will be used as the model for: Downscaling of continuous processing to facilitate fast-track process development for innovator and biosimilar monoclonal antibodies (mAbs) In-line and at-line process analytical monitoring of continuous [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.hollandbio.nl\/en\/nieuws\/biosana-and-astar-to-advance-continuous-biomanufacturing\/\" \/>\n<meta property=\"og:site_name\" content=\"hollandbio\" \/>\n<meta property=\"article:published_time\" content=\"2019-11-15T14:43:11+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-11-19T14:49:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2025\/01\/hb-opengraph_illu.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"hollandbio\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@hollandbio\" \/>\n<meta name=\"twitter:site\" content=\"@hollandbio\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"hollandbio\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/biosana-and-astar-to-advance-continuous-biomanufacturing\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/biosana-and-astar-to-advance-continuous-biomanufacturing\\\/\"},\"author\":{\"name\":\"hollandbio\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/person\\\/833d6a25b39946e61c6101af1fa96fbb\"},\"headline\":\"Biosana and A*STAR to advance continuous biomanufacturing\",\"datePublished\":\"2019-11-15T14:43:11+00:00\",\"dateModified\":\"2019-11-19T14:49:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/biosana-and-astar-to-advance-continuous-biomanufacturing\\\/\"},\"wordCount\":316,\"publisher\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#organization\"},\"articleSection\":[\"Innovatieklimaat\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/biosana-and-astar-to-advance-continuous-biomanufacturing\\\/\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/biosana-and-astar-to-advance-continuous-biomanufacturing\\\/\",\"name\":\"Biosana and A*STAR to advance continuous biomanufacturing - hollandbio\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#website\"},\"datePublished\":\"2019-11-15T14:43:11+00:00\",\"dateModified\":\"2019-11-19T14:49:33+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/biosana-and-astar-to-advance-continuous-biomanufacturing\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/biosana-and-astar-to-advance-continuous-biomanufacturing\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/biosana-and-astar-to-advance-continuous-biomanufacturing\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Biosana and A*STAR to advance continuous biomanufacturing\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/\",\"name\":\"hollandbio\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#organization\",\"name\":\"hollandbio\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/HollandBIO_logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.hollandbio.nl\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/HollandBIO_logo.svg\",\"width\":218.664,\"height\":29.659,\"caption\":\"hollandbio\"},\"image\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/hollandbio\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/hollandbio\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/person\\\/833d6a25b39946e61c6101af1fa96fbb\",\"name\":\"hollandbio\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Biosana and A*STAR to advance continuous biomanufacturing - hollandbio","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.hollandbio.nl\/en\/nieuws\/biosana-and-astar-to-advance-continuous-biomanufacturing\/","og_locale":"en_US","og_type":"article","og_title":"Biosana and A*STAR to advance continuous biomanufacturing - hollandbio","og_description":"BiosanaPharma and A*STAR\u2019s Bioprocessing Technology Institute (BTI) have signed a research collaboration to bring continuous biomanufacturing to the next level. Biosana\u2019s proprietary 3C process will be used as the model for: Downscaling of continuous processing to facilitate fast-track process development for innovator and biosimilar monoclonal antibodies (mAbs) In-line and at-line process analytical monitoring of continuous [&hellip;]","og_url":"https:\/\/www.hollandbio.nl\/en\/nieuws\/biosana-and-astar-to-advance-continuous-biomanufacturing\/","og_site_name":"hollandbio","article_published_time":"2019-11-15T14:43:11+00:00","article_modified_time":"2019-11-19T14:49:33+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2025\/01\/hb-opengraph_illu.png","type":"image\/png"}],"author":"hollandbio","twitter_card":"summary_large_image","twitter_creator":"@hollandbio","twitter_site":"@hollandbio","twitter_misc":{"Written by":"hollandbio","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/biosana-and-astar-to-advance-continuous-biomanufacturing\/#article","isPartOf":{"@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/biosana-and-astar-to-advance-continuous-biomanufacturing\/"},"author":{"name":"hollandbio","@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/person\/833d6a25b39946e61c6101af1fa96fbb"},"headline":"Biosana and A*STAR to advance continuous biomanufacturing","datePublished":"2019-11-15T14:43:11+00:00","dateModified":"2019-11-19T14:49:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/biosana-and-astar-to-advance-continuous-biomanufacturing\/"},"wordCount":316,"publisher":{"@id":"https:\/\/www.hollandbio.nl\/en\/#organization"},"articleSection":["Innovatieklimaat"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/biosana-and-astar-to-advance-continuous-biomanufacturing\/","url":"https:\/\/www.hollandbio.nl\/en\/nieuws\/biosana-and-astar-to-advance-continuous-biomanufacturing\/","name":"Biosana and A*STAR to advance continuous biomanufacturing - hollandbio","isPartOf":{"@id":"https:\/\/www.hollandbio.nl\/en\/#website"},"datePublished":"2019-11-15T14:43:11+00:00","dateModified":"2019-11-19T14:49:33+00:00","breadcrumb":{"@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/biosana-and-astar-to-advance-continuous-biomanufacturing\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.hollandbio.nl\/en\/nieuws\/biosana-and-astar-to-advance-continuous-biomanufacturing\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/biosana-and-astar-to-advance-continuous-biomanufacturing\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.hollandbio.nl\/en\/"},{"@type":"ListItem","position":2,"name":"Biosana and A*STAR to advance continuous biomanufacturing"}]},{"@type":"WebSite","@id":"https:\/\/www.hollandbio.nl\/en\/#website","url":"https:\/\/www.hollandbio.nl\/en\/","name":"hollandbio","description":"","publisher":{"@id":"https:\/\/www.hollandbio.nl\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.hollandbio.nl\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.hollandbio.nl\/en\/#organization","name":"hollandbio","url":"https:\/\/www.hollandbio.nl\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2023\/08\/HollandBIO_logo.svg","contentUrl":"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2023\/08\/HollandBIO_logo.svg","width":218.664,"height":29.659,"caption":"hollandbio"},"image":{"@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/hollandbio","https:\/\/www.linkedin.com\/company\/hollandbio\/"]},{"@type":"Person","@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/person\/833d6a25b39946e61c6101af1fa96fbb","name":"hollandbio"}]}},"_links":{"self":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/posts\/16023","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/comments?post=16023"}],"version-history":[{"count":0,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/posts\/16023\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/media?parent=16023"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/categories?post=16023"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/tags?post=16023"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}